William Blair Initiates Bullish Coverage on US Antimony Stock
William Blair starts coverage of United States Antimony with Outperform rating, citing soaring antimony prices and critical national security importance amid supply concerns.
William Blair starts coverage of United States Antimony with Outperform rating, citing soaring antimony prices and critical national security importance amid supply concerns.
WeightWatchers partners with Amazon Pharmacy to offer easier access to GLP-1 weight-loss drugs like Wegovy and Zepbound, especially for customers in rural areas with faster delivery options.
William Blair gives USA Rare Earth an Outperform rating, citing its integrated operations, proprietary technology, and potential for significant U.S. government investment.
Mizuho cuts Rivian rating to Underperform with $10 price target, citing expiring tax credits, weak EV demand, and lower 2026 delivery forecasts amid market headwinds.
Mizuho downgrades Skyworks to Underperform, cutting price target to $60. Analyst cites iPhone unit decline, foldable delays, and fading China subsidies as key concerns.
Activist investor Jana Partners targets Cooper Cos., advocating for a contact lens merger with Bausch + Lomb and strategic changes to boost shareholder value amid declining performance.